Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes: A Hybrid Design in a Real-World Setting

NCT07568574 is registered in ClinicalTrials.gov with Enhanced Emirates Limited as lead sponsor.

NCT NCT07568574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07568574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes: A Hybrid Design in a Real-World Setting
Lead sponsor
Enhanced Emirates Limited
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 12, 2026
Completion date
March 1, 2033
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety and impact of medically supervised performance enhancing substance usage in healthy elite athletes